Moderna Inc/ US60770K1079 /
20/05/2024 22:00:00 | Chg. +8.1100 | Volume | Bid11:51:12 | Ask11:51:12 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
141.0100USD | +6.10% | 4.71 mill. Turnover: 447.75 mill. |
139.0000Bid Size: 100 | 140.0000Ask Size: 400 | 54.04 bill.USD | - | - |
GlobeNewswire
12/05
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
08/05
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/05
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
02/05
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
01/05
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
01/05
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire
04/04
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
GlobeNewswire
04/03
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024